-
1
-
-
0002716935
-
Thee release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa
-
Bulbring E, Crema A. Thee release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol (Lond.) 1959; 146: 18-28.
-
(1959)
J Physiol (Lond.)
, vol.146
, pp. 18-28
-
-
Bulbring, E.1
Crema, A.2
-
2
-
-
0018140823
-
Fine structural classification and comparative distribution of endocrine cells in normal human large intestine
-
Cristina ML, Lehy T, Zeitoun P, Dufougeray F. Fine structural classification and comparative distribution of endocrine cells in normal human large intestine. Gastroenterology 1978; 75: 20-28.
-
(1978)
Gastroenterology
, vol.75
, pp. 20-28
-
-
Cristina, M.L.1
Lehy, T.2
Zeitoun, P.3
Dufougeray, F.4
-
3
-
-
0020501561
-
Endocrine cells in human intestine: An immunocytochemical study
-
Sjolund K, Sanden G, Hakanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983; 85: 1120-1130.
-
(1983)
Gastroenterology
, vol.85
, pp. 1120-1130
-
-
Sjolund, K.1
Sanden, G.2
Hakanson, R.3
Sundler, F.4
-
4
-
-
0025744281
-
Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of 5-HT3 receptors
-
Schworer H, Racke K, Kilbinger H. Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: involvement of 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol 1991; 344: 143-149.
-
(1991)
Naunyn Schmiedebergs Arch Pharmacol
, vol.344
, pp. 143-149
-
-
Schworer, H.1
Racke, K.2
Kilbinger, H.3
-
5
-
-
0022461509
-
Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors
-
Richter G, Stockmann F, Conlon JM, Creutzfeldt W. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology 1986; 91: 612-618.
-
(1986)
Gastroenterology
, vol.91
, pp. 612-618
-
-
Richter, G.1
Stockmann, F.2
Conlon, J.M.3
Creutzfeldt, W.4
-
6
-
-
0028183017
-
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)
-
Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
-
(1994)
Pharmacol Rev
, vol.46
, pp. 157-203
-
-
Hoyer, D.1
Clarke, D.E.2
Fozard, J.R.3
-
7
-
-
0027488084
-
Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret
-
Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993; 45: 51-59.
-
(1993)
J Auton Nerv Syst
, vol.45
, pp. 51-59
-
-
Blackshaw, L.A.1
Grundy, D.2
-
8
-
-
0025230892
-
The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology, and plasticity
-
Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 1990; 68: 325-345.
-
(1990)
Can J Physiol Pharmacol
, vol.68
, pp. 325-345
-
-
Andrews, P.L.1
Davis, C.J.2
Bingham, S.3
Davidson, H.I.4
Hawthorn, J.5
Maskell, L.6
-
9
-
-
0026643829
-
Changes in serotonin metabolism in cancer patients. Its relationship to nausea and vomiting induced by chemotherapeutic drugs
-
Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ. Changes in serotonin metabolism in cancer patients. Its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 1992; 66: 198-203.
-
(1992)
Br J Cancer
, vol.66
, pp. 198-203
-
-
Cubeddu, L.X.1
Hoffmann, I.S.2
Fuenmayor, N.T.3
Malave, J.J.4
-
10
-
-
0026513238
-
Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: Activity-induced expression of Fos immunoreactivity
-
Kirchgessner AL, Tamir H, Gershon MD. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci 1992; 12: 235-248.
-
(1992)
J Neurosci
, vol.12
, pp. 235-248
-
-
Kirchgessner, A.L.1
Tamir, H.2
Gershon, M.D.3
-
11
-
-
0031836108
-
Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans
-
Lordal M, Wallen H, Hjemdahl P, Beck O, Hellstrom PM. Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. Clin Sci (Colch) 1998; 94: 663-670.
-
(1998)
Clin Sci (Colch)
, vol.94
, pp. 663-670
-
-
Lordal, M.1
Wallen, H.2
Hjemdahl, P.3
Beck, O.4
Hellstrom, P.M.5
-
12
-
-
0028301413
-
Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome
-
Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159-166.
-
(1994)
Aliment Pharmacol Ther
, vol.8
, pp. 159-166
-
-
Gorard, D.A.1
Libby, G.W.2
Farthing, M.J.3
-
13
-
-
0026073219
-
Intestinal motility changes in rats after enteric serotonergic neuron destruction
-
Pineiro-Carrero VM, Clench MH, Davis RH, Andres JM, Franzini DA, Mathias JR. Intestinal motility changes in rats after enteric serotonergic neuron destruction. Am J Physiol 1991; 260: G232-G239.
-
(1991)
Am J Physiol
, vol.260
-
-
Pineiro-Carrero, V.M.1
Clench, M.H.2
Davis, R.H.3
Andres, J.M.4
Franzini, D.A.5
Mathias, J.R.6
-
14
-
-
0033005212
-
Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine
-
Lordal M, Hellstrom PM. Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine. Neurogastroenterol Motil 1999; 11: 1-10.
-
(1999)
Neurogastroenterol Motil
, vol.11
, pp. 1-10
-
-
Lordal, M.1
Hellstrom, P.M.2
-
15
-
-
4243300063
-
MKC-733, a selective 5-HT3 receptor agonist stimulates fasting human antral motility
-
Coleman NS, Wright J, Parker M, Spiller RC. MKC-733, a selective 5-HT3 receptor agonist stimulates fasting human antral motility. Gastroenterology 2001; 120: A460-A461.
-
(2001)
Gastroenterology
, vol.120
-
-
Coleman, N.S.1
Wright, J.2
Parker, M.3
Spiller, R.C.4
-
16
-
-
4244011584
-
MKC-733, a selective 5-HT3 receptor agonist stimulates small bowel transit and relaxes the gastric fundus in man
-
Coleman NS, Marciani L, Blackshaw PE, Gowland PA, Perkins AC, Spiller RC. MKC-733, a selective 5-HT3 receptor agonist stimulates small bowel transit and relaxes the gastric fundus in man. Gastroenterology 2001; 120: A71.
-
(2001)
Gastroenterology
, vol.120
-
-
Coleman, N.S.1
Marciani, L.2
Blackshaw, P.E.3
Gowland, P.A.4
Perkins, A.C.5
Spiller, R.C.6
-
17
-
-
0027305518
-
5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans
-
Wilmer A, Tack J, Coremans G, Janssens J, Peeters T, Vantrappen G. 5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans. Gastroenterology 1993; 105: 773-780.
-
(1993)
Gastroenterology
, vol.105
, pp. 773-780
-
-
Wilmer, A.1
Tack, J.2
Coremans, G.3
Janssens, J.4
Peeters, T.5
Vantrappen, G.6
-
18
-
-
0025753446
-
Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog
-
Itoh Z, Mizumoto A, Iwanaga Y, Yoshida N, Torii K, Wakabayashi K. Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog. Gastroenterology 1991; 100: 901-908.
-
(1991)
Gastroenterology
, vol.100
, pp. 901-908
-
-
Itoh, Z.1
Mizumoto, A.2
Iwanaga, Y.3
Yoshida, N.4
Torii, K.5
Wakabayashi, K.6
-
20
-
-
0026418189
-
Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid
-
Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 1991; 351: 477-479.
-
(1991)
Nature
, vol.351
, pp. 477-479
-
-
Desai, K.M.1
Sessa, W.C.2
Vane, J.R.3
-
21
-
-
0034070874
-
Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man
-
Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46: 468-473.
-
(2000)
Gut
, vol.46
, pp. 468-473
-
-
Tack, J.1
Coulie, B.2
Wilmer, A.3
Andrioli, A.4
Janssens, J.5
-
22
-
-
0029859119
-
Gastric antisecretory effect of serotonin: Quantitation of release and site of action
-
Lepard KJ, Chi J, Mohammed JR, Gidener S, Stephens RL Jr. Gastric antisecretory effect of serotonin: quantitation of release and site of action. Am J Physiol 1996; 271: E669-E677.
-
(1996)
Am J Physiol
, vol.271
-
-
Lepard, K.J.1
Chi, J.2
Mohammed, J.R.3
Gidener, S.4
Stephens R.L., Jr.5
-
23
-
-
0025895099
-
BRL 24924, a 5-hydroxytryptamine type 3 antagonist, and gastric secretion of acid and pepsin in vivo
-
Johansen B, Bech K. BRL 24924, a 5-hydroxytryptamine type 3 antagonist, and gastric secretion of acid and pepsin in vivo. Digestion 1991; 48: 121-127.
-
(1991)
Digestion
, vol.48
, pp. 121-127
-
-
Johansen, B.1
Bech, K.2
-
24
-
-
0029830522
-
Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine
-
Foxx-Orenstein AE, Kuemmerle JF, Grider JR. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996; 111: 1281-1290.
-
(1996)
Gastroenterology
, vol.111
, pp. 1281-1290
-
-
Foxx-Orenstein, A.E.1
Kuemmerle, J.F.2
Grider, J.R.3
-
25
-
-
0031595212
-
5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine
-
Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-380.
-
(1998)
Gastroenterology
, vol.115
, pp. 370-380
-
-
Grider, J.R.1
Foxx-Orenstein, A.E.2
Jin, J.G.3
-
26
-
-
0029976793
-
5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons
-
Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons. Am J Physiol 1996; 270: G778-G782.
-
(1996)
Am J Physiol
, vol.270
-
-
Grider, J.R.1
Kuemmerle, J.F.2
Jin, J.G.3
-
27
-
-
0030278350
-
Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon
-
Kadowaki M, Wade PR, Gershon MD. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Am J Physiol 1996; 271: G849-G857.
-
(1996)
Am J Physiol
, vol.271
-
-
Kadowaki, M.1
Wade, P.R.2
Gershon, M.D.3
-
28
-
-
0033939079
-
The inhibition of cholera toxin-induced 5-HT release by the 5-HT (3) receptor antagonist, granisetron, in the rat
-
In Process Citation
-
Turvill JL, Connor P, Farthing MJ. The inhibition of cholera toxin-induced 5-HT release by the 5-HT (3) receptor antagonist, granisetron, in the rat [In Process Citation]. Br J Pharmacol 2000; 130: 1031-1036.
-
(2000)
Br J Pharmacol
, vol.130
, pp. 1031-1036
-
-
Turvill, J.L.1
Connor, P.2
Farthing, M.J.3
-
29
-
-
0033850197
-
Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins
-
Mourad FH, Nassar CF. Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut 2000; 47: 382-386.
-
(2000)
Gut
, vol.47
, pp. 382-386
-
-
Mourad, F.H.1
Nassar, C.F.2
-
30
-
-
0031563282
-
Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea-pig colon
-
Cooke HJ, Sidhu M, Wang YZ. Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea-pig colon. J Auton Nerv Syst 1997; 66: 105-110.
-
(1997)
J Auton Nerv Syst
, vol.66
, pp. 105-110
-
-
Cooke, H.J.1
Sidhu, M.2
Wang, Y.Z.3
-
31
-
-
0033862394
-
Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon
-
Stoner MC, Scherr AM, Lee JA, Wolfe LG, Kellum JM. Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon. Surgery 2000; 128: 240-245.
-
(2000)
Surgery
, vol.128
, pp. 240-245
-
-
Stoner, M.C.1
Scherr, A.M.2
Lee, J.A.3
Wolfe, L.G.4
Kellum, J.M.5
-
32
-
-
0024586843
-
Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo
-
Beubler E, Kollar G, Saria A, Bukhave K, Rask-Madsen J. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 1989; 96: 368-376.
-
(1989)
Gastroenterology
, vol.96
, pp. 368-376
-
-
Beubler, E.1
Kollar, G.2
Saria, A.3
Bukhave, K.4
Rask-Madsen, J.5
-
33
-
-
0030833013
-
In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: A segmental perfusion study
-
Bearcroft CP, Andre EA, Farthing MJ. In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther 1997; 11: 1109-1114.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 1109-1114
-
-
Bearcroft, C.P.1
Andre, E.A.2
Farthing, M.J.3
-
34
-
-
0030600410
-
The role of the 5-HT4 receptor in Cl-secretion in human jejunal mucosa
-
Budhoo MR, Harris RP, Kellum JM. The role of the 5-HT4 receptor in Cl-secretion in human jejunal mucosa. Eur J Pharmacol 1996; 314: 109-114.
-
(1996)
Eur J Pharmacol
, vol.314
, pp. 109-114
-
-
Budhoo, M.R.1
Harris, R.P.2
Kellum, J.M.3
-
35
-
-
0027131630
-
Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT
-
Borman RA, Burleigh DE. Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT. Br J Pharmacol 1993; 110: 927-928.
-
(1993)
Br J Pharmacol
, vol.110
, pp. 927-928
-
-
Borman, R.A.1
Burleigh, D.E.2
-
36
-
-
0027469647
-
Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome
-
Prior A, Read NW. Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-180.
-
(1993)
Aliment Pharmacol Ther
, vol.7
, pp. 175-180
-
-
Prior, A.1
Read, N.W.2
-
37
-
-
0032159413
-
Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex
-
Bjornsson ES, Chey WD, Ladabaum U, et al. Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex. Am J Physiol 1998; 275: G498-G505.
-
(1998)
Am J Physiol
, vol.275
-
-
Bjornsson, E.S.1
Chey, W.D.2
Ladabaum, U.3
-
38
-
-
0024999306
-
Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist
-
Gore S, Gilmore IT, Haigh CG, Brownless SM, Stockdale H, Morris AI. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther 1990; 4: 139-144.
-
(1990)
Aliment Pharmacol Ther
, vol.4
, pp. 139-144
-
-
Gore, S.1
Gilmore, I.T.2
Haigh, C.G.3
Brownless, S.M.4
Stockdale, H.5
Morris, A.I.6
-
39
-
-
0025219706
-
GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man
-
Talley NJ, Phillips SF, Haddad A, et al. GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Digestive Dis Sci 1990; 35: 477-480.
-
(1990)
Digestive Dis Sci
, vol.35
, pp. 477-480
-
-
Talley, N.J.1
Phillips, S.F.2
Haddad, A.3
-
40
-
-
0028182404
-
A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea
-
von O, Camilleri M, Kvols LK. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994; 106: 1184-1189.
-
(1994)
Gastroenterology
, vol.106
, pp. 1184-1189
-
-
Von, O.1
Camilleri, M.2
Kvols, L.K.3
-
42
-
-
0031658491
-
Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
-
Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998; 12: 849-855.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 849-855
-
-
Delvaux, M.1
Louvel, D.2
Mamet, J.P.3
Campos-Oriola, R.4
Frexinos, J.5
-
43
-
-
0032589966
-
Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers
-
Poen AC, Felt-Bersma RJ, Van Dongen PA, Meuwissen SG. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Aliment Pharmacol Ther 1999; 13: 1493-1497.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1493-1497
-
-
Poen, A.C.1
Felt-Bersma, R.J.2
Van Dongen, P.A.3
Meuwissen, S.G.4
-
44
-
-
0033005188
-
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans
-
Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999; 44: 682-686.
-
(1999)
Gut
, vol.44
, pp. 682-686
-
-
Bouras, E.P.1
Camilleri, M.2
Burton, D.D.3
McKinzie, S.4
-
45
-
-
0001030304
-
The 5-HT4 receptor partial agonist tegaserod (HTF919) accelerates upper and lower gastrointestinal (GI) transit
-
Degen L, Matzinger D, Merz M, et al. The 5-HT4 receptor partial agonist tegaserod (HTF919) accelerates upper and lower gastrointestinal (GI) transit. Gastroenterology 2000; 118: A845.
-
(2000)
Gastroenterology
, vol.118
-
-
Degen, L.1
Matzinger, D.2
Merz, M.3
-
46
-
-
0343145638
-
Post-synaptic 5-HT4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae
-
Goldhill J, Porquet MF, Angel I. Post-synaptic 5-HT4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae. Eur J Pharmacol 1997; 323: 229-233.
-
(1997)
Eur J Pharmacol
, vol.323
, pp. 229-233
-
-
Goldhill, J.1
Porquet, M.F.2
Angel, I.3
-
47
-
-
0024511561
-
Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum
-
Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 1989; 96: 1257-1264.
-
(1989)
Gastroenterology
, vol.96
, pp. 1257-1264
-
-
Tonini, M.1
Galligan, J.J.2
North, R.A.3
-
49
-
-
0029862629
-
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia
-
Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-1042.
-
(1996)
Gastroenterology
, vol.110
, pp. 1036-1042
-
-
Stanghellini, V.1
Tosetti, C.2
Paternico, A.3
-
50
-
-
0031731346
-
Role of impaired gastric accommodation to a meal in functional dyspepsia
-
Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia [see comments]. Gastroenterology 1998; 115: 1346-1352.
-
(1998)
Gastroenterology
, vol.115
, pp. 1346-1352
-
-
Tack, J.1
Piessevaux, H.2
Coulie, B.3
Caenepeel, P.4
Janssens, J.5
-
51
-
-
0033003317
-
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function
-
Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999; 44: 55-64.
-
(1999)
Gut
, vol.44
, pp. 55-64
-
-
Thumshirn, M.1
Camilleri, M.2
Saslow, S.B.3
Williams, D.E.4
Burton, D.D.5
Hanson, R.B.6
-
52
-
-
0025128853
-
Bacteriotherapy for Clostridium difficile diarrhoea
-
Tvede M, RaskMadsen J. Bacteriotherapy for Clostridium difficile diarrhoea. Lancet 1990; 335: 110.
-
(1990)
Lancet
, vol.335
, pp. 110
-
-
Tvede, M.1
RaskMadsen, J.2
-
53
-
-
0031876343
-
The influence of cisapride on gastric tone and the perception of gastric distension
-
Tack J, Broeckaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 761-766.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 761-766
-
-
Tack, J.1
Broeckaert, D.2
Coulie, B.3
Janssens, J.4
-
54
-
-
0031022678
-
Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study
-
de Groot GH, de Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997; 11: 193-199.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 193-199
-
-
De Groot, G.H.1
De Both, P.S.2
-
55
-
-
0028952152
-
Efficacy of cisapride therapy in functional dyspepsia
-
Kellow JE, Cowan H, Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 153-160.
-
(1995)
Aliment Pharmacol Ther
, vol.9
, pp. 153-160
-
-
Kellow, J.E.1
Cowan, H.2
Shuter, B.3
-
56
-
-
0032421118
-
The effect of cisapride on dysmotility-like functional dyspepsia: Reduction of the fasting and postprandial area, but not of the postprandial antral expansion
-
Eberl T, Barnert J, Dumitrascu DL, Fischer J, Wienbeck M. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion. Eur J Gastroenterol Hepatol 1998; 10: 991-995.
-
(1998)
Eur J Gastroenterol Hepatol
, vol.10
, pp. 991-995
-
-
Eberl, T.1
Barnert, J.2
Dumitrascu, D.L.3
Fischer, J.4
Wienbeck, M.5
-
57
-
-
0031744654
-
Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia
-
Finney JS, Kinnersley N, Hughes M, O'Bryan-Tear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312-320.
-
(1998)
J Clin Gastroenterol
, vol.26
, pp. 312-320
-
-
Finney, J.S.1
Kinnersley, N.2
Hughes, M.3
O'Bryan-Tear, C.G.4
Lothian, J.5
-
58
-
-
0034051862
-
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis
-
Mansi C, Borro P, Giacomini M, et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000; 14: 561-569.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 561-569
-
-
Mansi, C.1
Borro, P.2
Giacomini, M.3
-
59
-
-
0001542218
-
Functional dyspepsia. Impaired fundic accommodation
-
Tack J. Functional dyspepsia. Impaired fundic accommodation. Curr Treat Options Gastroenterol 2000; 3: 287-294.
-
(2000)
Curr Treat Options Gastroenterol
, vol.3
, pp. 287-294
-
-
Tack, J.1
-
60
-
-
0032872312
-
Serotonin receptor physiology: Relation to emesis
-
Hasler WL. Serotonin receptor physiology: relation to emesis. Dig Dis Sci 1999; 44: 108S-13S.
-
(1999)
Dig Dis Sci
, vol.44
-
-
Hasler, W.L.1
-
62
-
-
0032694283
-
Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples
-
Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol 1999; 34: 993-1000.
-
(1999)
Scand J Gastroenterol
, vol.34
, pp. 993-1000
-
-
Ragnarsson, G.1
Bodemar, G.2
-
63
-
-
0031777140
-
Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study
-
Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415-421.
-
(1998)
Eur J Gastroenterol Hepatol
, vol.10
, pp. 415-421
-
-
Ragnarsson, G.1
Bodemar, G.2
-
64
-
-
0029848204
-
Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron)
-
Goldberg PA, Kamm MA, Setti-Carraro P, Van den Sijp JR, Roth C. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion 1996; 57: 478-483.
-
(1996)
Digestion
, vol.57
, pp. 478-483
-
-
Goldberg, P.A.1
Kamm, M.A.2
Setti-Carraro, P.3
Van den Sijp, J.R.4
Roth, C.5
-
65
-
-
0026741853
-
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: A pilot study
-
Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: A pilot study. Mayo Clinic Proceedings 1992; 67: 732-738.
-
(1992)
Mayo Clinic Proceedings
, vol.67
, pp. 732-738
-
-
Steadman, C.J.1
Talley, N.J.2
Phillips, S.F.3
Zinsmeister, A.R.4
-
66
-
-
0033625752
-
Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers
-
Houghton LA, Foster JM, Whorwell PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 2000; 14: 775-782.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 775-782
-
-
Houghton, L.A.1
Foster, J.M.2
Whorwell, P.J.3
-
67
-
-
0003124927
-
Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (DI-IBS)
-
Viramontes B, McKinzie S, Pardi DS, Burton D, Thomforde GM, Camilleri M. Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (DI-IBS). Gastroenterology 2000; 118: A848.
-
(2000)
Gastroenterology
, vol.118
-
-
Viramontes, B.1
McKinzie, S.2
Pardi, D.S.3
Burton, D.4
Thomforde, G.M.5
Camilleri, M.6
-
68
-
-
0033963225
-
A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome
-
Bardhan KD, Bodemar G, Geldof H, Schutz E, Heath A, Mills JG, et al. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2000; 14: 23-34.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 23-34
-
-
Bardhan, K.D.1
Bodemar, G.2
Geldof, H.3
Schutz, E.4
Heath, A.5
Mills, J.G.6
-
69
-
-
0032848856
-
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist
-
Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999; 13: 1149-1159.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1149-1159
-
-
Camilleri, M.1
Mayer, E.A.2
Drossman, D.A.3
-
70
-
-
0034712539
-
Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial
-
Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [see comments]. Lancet 2000; 355: 1035-1040.
-
(2000)
Lancet
, vol.355
, pp. 1035-1040
-
-
Camilleri, M.1
Northcutt, A.R.2
Kong, S.3
Dukes, G.E.4
McSorley, D.5
Mangel, A.W.6
-
72
-
-
0032749795
-
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients
-
Jones RH, Holtmann G, Rodrigo L, et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment Pharmacol Ther 1999; 13: 1419-1427.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1419-1427
-
-
Jones, R.H.1
Holtmann, G.2
Rodrigo, L.3
-
73
-
-
0033755876
-
Effects of a serotonin 5-HT (4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans
-
In Process Citation
-
Bharucha AE, Camilleri M, Haydock S, et al. Effects of a serotonin 5-HT (4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans [In Process Citation]. Gut 2000; 47: 667-674.
-
(2000)
Gut
, vol.47
, pp. 667-674
-
-
Bharucha, A.E.1
Camilleri, M.2
Haydock, S.3
-
74
-
-
0023073699
-
Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects
-
Edwards CA, Holden S, Brown C, Read NW. Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 1987; 28: 13-16.
-
(1987)
Gut
, vol.28
, pp. 13-16
-
-
Edwards, C.A.1
Holden, S.2
Brown, C.3
Read, N.W.4
-
75
-
-
0023220564
-
Treatment of chronic constipation with cisapride and placebo
-
Muller-Lissner SA. Treatment of chronic constipation with cisapride and placebo. Gut 1987; 28: 1033-1038.
-
(1987)
Gut
, vol.28
, pp. 1033-1038
-
-
Muller-Lissner, S.A.1
-
76
-
-
0026015978
-
'Prokinetic' treatment of constipation-predominant irritable bowel syndrome: A placebo-controlled study of cisapride
-
Van Outryve M, Milo R, Toussaint J, Van Eeghem P. 'Prokinetic' treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991; 13: 49-57.
-
(1991)
J Clin Gastroenterol
, vol.13
, pp. 49-57
-
-
Van Outryve, M.1
Milo, R.2
Toussaint, J.3
Van Eeghem, P.4
-
77
-
-
0030967149
-
Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome
-
Schutze K, Brandstatter G, Dragosics B, Judmaier G, Hentschel E. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 387-394.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 387-394
-
-
Schutze, K.1
Brandstatter, G.2
Dragosics, B.3
Judmaier, G.4
Hentschel, E.5
-
78
-
-
0031932212
-
The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation
-
Farup PG, Hovdenak N, Wetterhus S, Lange OJ, Hovde O, Trondstad R. The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation. Scand J Gastroenterol 1998; 33: 128-131.
-
(1998)
Scand J Gastroenterol
, vol.33
, pp. 128-131
-
-
Farup, P.G.1
Hovdenak, N.2
Wetterhus, S.3
Lange, O.J.4
Hovde, O.5
Trondstad, R.6
-
79
-
-
0001525965
-
Investigations on a 5HT4 agonistt (SDZ HTF 919) and its main metabolite in conscious dogs: Effects on gastrointestinal motility and impaired gastric emptying
-
Fioramonti J, Million M, Bueno L. Investigations on a 5HT4 agonistt (SDZ HTF 919) and its main metabolite in conscious dogs: effects on gastrointestinal motility and impaired gastric emptying. Gastroenterology 2000; 114: A752.
-
(2000)
Gastroenterology
, vol.114
-
-
Fioramonti, J.1
Million, M.2
Bueno, L.3
-
80
-
-
0001394241
-
Effeects of tegaserod (HTF919) on gastrointtestinal motility and transit in awake rats
-
Huge A, Zittel TT, Kreis ME, Becker HD, Jehle EC. Effeects of tegaserod (HTF919) on gastrointtestinal motility and transit in awake rats. Gastroenterology 2000; 118: A403.
-
(2000)
Gastroenterology
, vol.118
-
-
Huge, A.1
Zittel, T.T.2
Kreis, M.E.3
Becker, H.D.4
Jehle, E.C.5
-
81
-
-
0031412762
-
Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit
-
Appel S, Kumle A, Meier R. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit. Clin Pharmacol Ther 1997; 62: 546-555.
-
(1997)
Clin Pharmacol Ther
, vol.62
, pp. 546-555
-
-
Appel, S.1
Kumle, A.2
Meier, R.3
-
82
-
-
0034089045
-
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
-
Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118: 463-468.
-
(2000)
Gastroenterology
, vol.118
, pp. 463-468
-
-
Prather, C.M.1
Camilleri, M.2
Zinsmeister, A.R.3
McKinzie, S.4
Thomforde, G.5
-
83
-
-
0003220750
-
Tegaserod, a partial 5-HT4 agonist improves abdominal discomfort/pain and altered bowel function in irritable bowel syndrome (IBS)
-
Schmitt C, Krumholz S, Tanghe J, Heggland J, Shi Y, Lefkowitz MP. Tegaserod, a partial 5-HT4 agonist improves abdominal discomfort/pain and altered bowel function in irritable bowel syndrome (IBS). Gut 1999; 45: A258.
-
(1999)
Gut
, vol.45
-
-
Schmitt, C.1
Krumholz, S.2
Tanghe, J.3
Heggland, J.4
Shi, Y.5
Lefkowitz, M.P.6
-
84
-
-
0001626523
-
4 partial agonist, Tegaserod, improves abdominal bloating and altered stool consistency in irritable bowel syndrome (IBS)
-
4 partial agonist, Tegaserod, improves abdominal bloating and altered stool consistency in irritable bowel syndrome (IBS). Gut 1999; 45: A260.
-
(1999)
Gut
, vol.45
-
-
Krumholz, S.1
Tanghe, J.2
Schmitt, C.3
Heggland, J.4
Shi, Y.5
Ruegg, P.6
-
85
-
-
0034794595
-
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
-
Mueller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 1655-1666.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1655-1666
-
-
Mueller-Lissner, S.A.1
Fumagalli, I.2
Bardhan, K.D.3
-
86
-
-
0024427722
-
Cisapride accelerates colonic transit in constipated patients with colonic inertia
-
Krevsky B, Maurer AH, Malmud LS, Fisher RS. Cisapride accelerates colonic transit in constipated patients with colonic inertia [see comments]. Am J Gastroenterol 1989; 84: 882-887.
-
(1989)
Am J Gastroenterol
, vol.84
, pp. 882-887
-
-
Krevsky, B.1
Maurer, A.H.2
Malmud, L.S.3
Fisher, R.S.4
-
87
-
-
0028801876
-
The effect of cisapride on segmental colonic transit time in patients with spinal cord injury
-
Geders JM, Gaing A, Bauman WA, Korsten MA. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. Am J Gastroenterol 1995; 90: 285-289.
-
(1995)
Am J Gastroenterol
, vol.90
, pp. 285-289
-
-
Geders, J.M.1
Gaing, A.2
Bauman, W.A.3
Korsten, M.A.4
-
88
-
-
4243385591
-
Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation
-
Emmanuel AV, Nichols T, Roy AJ, Antonelli K, Kamm MA. Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation. Gastroenterology 2000; 118: A846.
-
(2000)
Gastroenterology
, vol.118
-
-
Emmanuel, A.V.1
Nichols, T.2
Roy, A.J.3
Antonelli, K.4
Kamm, M.A.5
-
89
-
-
0032754503
-
L-Type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: An in situ study
-
Lomax RB, Gallego S, Novalbos J, Garcia AG, Warhurst G. L-Type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: an in situ study. Gastroenterology 1999; 117: 1363-1369.
-
(1999)
Gastroenterology
, vol.117
, pp. 1363-1369
-
-
Lomax, R.B.1
Gallego, S.2
Novalbos, J.3
Garcia, A.G.4
Warhurst, G.5
|